Cannabidiol (CBD) is a cannabinoid found in hemp plants that has remarkable medical effects but does not make patients feel the "high" and actually counters some of the effects of THC. After decades in which only high-THC Cannabis was available, CBD-rich strains are now being grown by and for medical users.
Easing of Symptoms.
Scientific and clinical studies indicate that CBD could be effective in easing symptoms of a wide range of difficult-to-control conditions, including: rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, antibiotic-resistant infections and neurological disorders.
CBD has demonstrated neuroprotective effects, and its anti-cancer potential is currently being explored at several academic research centers in the U.S. and other countries.
Cromogen is the sole pharmaceutical company in the Americas focused on cannabinoid-class medicines. Our research team is achieving a global first by conducting stage 3 clinical trials for severe nausea caused by cytotoxic antineoplastic therapies.
we are developing medicines for some of the world’s most serious diseases.
For the employees,
we provide a culture in which they can feel appreciated, energized, and rewarded for their contribution.
For the wider community,
we want to be valued for not only the contribution our medicines make to society, but the philanthropic initiatives our company brings forth.
we are on the cutting edge of development in cannabinoid class pharmaceuticals and molecule groups.